Ethical Issues of Gene Therapy

The world trade market for cell and gene based therapies is expected to greater than the $20 billion USD mark by 2025, with an annual growth rate of 21%. The main targets for cell based therapies are high impact disease areas with significant incurable needs, including cancer, heart disease, neurodegenerative diseases, musculoskeletal disorders and autoimmune diseases gene therapies should then not be rushed to market but companies should gather the required data about the impact of therapy in human community with the appropriate duration of follow-up to allow proper evaluation by payers.

 

    Related Conference of Ethical Issues of Gene Therapy

    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    June 28-30 2020

    Stroke Summit 2020

    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    July 15-16, 2020

    25th World Biotechnology Congress

    London, UK
    September 21-22, 2020

    14th International Conference on Genomics & Pharmacogenomics

    Vancouver, Canada
    September 23-24, 2020

    24th European Biotechnology Congress

    Berlin, Germany
    October 19-20, 2020

    7th Asia Pacific Geriatrics and Gerontology Congress

    Tokyo, Japan
    October 23-24, 2020

    2nd International Conference on Biomarkers and Cancer Targets

    Cape Town, South Africa
    November 16-17, 2020

    International Conference on Genomics and Molecular Biology

    Lisbon, Portugal
    November 23-24, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia
    December 07- 08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 14-15, 2020

    New frontiers in Genetics Research & Advanced Techniques

    San Antonio, USA

    Ethical Issues of Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in